Comprehensive Analysis of Vascular Endothelial Growth Factor-C Related Factors in Stomach Cancer |
Liu, Yong-Chao
(Department of General Surgery, Huashan Hospital, Fudan University)
Zhao, Jing (Department of Infectious Diseases, Huashan Hospital, Fudan University) Hu, Cheng-En (Department of General Surgery, Huashan Hospital, Fudan University) Gan, Jun (Department of General Surgery, Huashan Hospital, Fudan University) Zhang, Wen-Hong (Department of Infectious Diseases, Huashan Hospital, Fudan University) Huang, Guang-Jian (Department of General Surgery, Huashan Hospital, Fudan University) |
1 | Wu WK, Cho CH, Lee CW, et al (2010). Dysregulation of cellular signaling in gastric cancer. Cancer Lett, 295, 144-53. DOI ScienceOn |
2 | Wang CA, Jedlicka P, Patrick AN, et al (2012). SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Invest, 122, 1895-906. DOI |
3 | Wang J, Guo Y, Wang B, et al (2012). Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature. Mol Biol Rep, 39, 11153-65. DOI |
4 | Wang Z, Chen Y, Li X, et al (2012). Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis. Asian Pac J Cancer Prev, 13, 27-31. 과학기술학회마을 DOI ScienceOn |
5 | Zhu C, Qi X, Chen Y, et al (2011). PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res Clin Oncol, 137, 1587-94. DOI ScienceOn |
6 | Liu Y, Zhang C, Fan J, et al (2011). Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer. World J Surg Oncol, 9, 121. DOI |
7 | Kumar JP (2009). The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease. Cell Mol Life Sci, 66, 565-83. DOI ScienceOn |
8 | Le Grand F, Grifone R, Mourikis P, et al (2012). Six1 regulates stem cell repair potential and self-renewal during skeletal muscle regeneration. J Cell Biol, 198, 815-32. DOI |
9 | Liu P, Zhou J, Zhu H, et al (2011). VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression. Cytokine, 55, 8-17. DOI |
10 | Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods, 25, 402-8. DOI ScienceOn |
11 | Su JL, Yen CJ, Chen PS, et al (2007). The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer, 96, 541-5. DOI ScienceOn |
12 | Maillet M, Purcell NH, Sargent MA, et al (2008). DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility. J Biol Chem, 283, 31246-55. DOI |
13 | Peng C, Sun Q, Fang Y, et al (2011). VEGF-C antisense oligoxydeonucleotide suppression of invasive ability of the A-549 lung carcinoma cell line. Asian Pac J Cancer Prev, 12, 2097-9. |
14 | Su JL, Yang PC, Shih JY, et al (2006). The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell, 9, 209-23. DOI |
15 | Tsai PW, Shiah SG, Lin MT, et al (2003). Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem, 278, 5750-9. DOI |
16 | Christensen KL, Patrick AN, McCoy EL, Ford HL (2008). The six family of homeobox genes in development and cancer. Adv Cancer Res, 101, 93-126. DOI |
17 | Arigami T, Natsugoe S, Uenosono Y, et al (2009). Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer. J Surg Oncol, 99, 148-53. DOI |
18 | Cao Y (2008). Why and how do tumors stimulate lymphangiogenesis? Lymphat Res Biol, 6, 145-8. DOI |
19 | Cejudo-Marin R, Tarrega C, Nunes-Xavier CE, Pulido R (2012). Caspase-3 cleavage of DUSP6/MKP3 at the interdomain region generates active MKP3 fragments that regulate ERK1/2 subcellular localization and function. J Mol Biol, 420, 128-38. DOI |
20 | Furukawa T, Tanji E, Xu S, Horii A (2008). Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells. Biochem Biophys Res Commun, 377, 317-20. DOI |
21 | Guggenheim DE, Shah MA (2012). Gastric cancer epidemiology and risk factors. J Surg Oncol, 107, 230-6. |
22 | Jennbacken K, Vallbo C, Wang W, Damber JE (2005). Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate, 65, 110-6. DOI |
23 | Joukov V, Pajusola K, Kaipainen A, et al (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J, 15, 290-98. |
24 | Joukov V, Sorsa T, Kumar V, et al (1997). Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J, 16, 3898-911. DOI ScienceOn |
25 | Kodama M, Kitadai Y, Tanaka M, et al (2008). Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Clin Cancer Res, 14, 7205-14. DOI |
26 | Achen MG, Stacker SA (2008). Molecular control of lymphatic metastasis. Ann N Y Acad Sci, 1131, 225-34. DOI |
27 | Alitalo K, Carmeliet P (2002). Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell, 1, 219-27. DOI ScienceOn |
28 | Amioka T, Kitadai Y, Tanaka S, et al (2002). Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer, 38, 1413-9. DOI ScienceOn |
![]() |